Age of AI Europe, 2026
March 10, 2026 · London
Learn more >
Amman Ayub
Lead Counsel, UK & Ireland
Advanz Pharma
Amman Ayub is Lead Counsel, UK & Ireland at Advanz Pharma and has over 12 years’ experience advising within the pharmaceutical and medical aesthetics sectors. An early adopter of AI, Amman is particularly interested in how AI can be used pragmatically and responsibly within legal teams, balancing innovation with regulatory and ethical considerations.
Sessions
Pav Rishiraj
10:50 AM – 11:30 AM
A Real Debate on What’s Coming Next: Ethics, Regulation & the EU AI Act
- The EU’s AI Act will reshape how pharma markets, personalises, and measures. This panel explore pharma frameworks, and how to stay compliant without holding back innovation.
Outcome: Leave a strong understanding of how AI solutions may violate the EU AI Act. Critical for those tasked with rolling out global initiatives in EU markets.
Pav Rishiraj, Director, Head of Pharmacovigilance & UK QPPV, IPSEN & ABPI Chair of Pharma Convigilance
Jasmine Agyekum,, Senior Associate, Clifford Chance
Amman Ayub, Lead Counsel, UK & Ireland, Advanz Pharma